-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
LogicBio Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2017 to Q3 2022.
- LogicBio Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was -$31K, a 88.5% increase year-over-year.
- LogicBio Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was -$654K, a 39.7% increase year-over-year.
- LogicBio Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.07M, a 16.3% decline from 2020.
- LogicBio Therapeutics, Inc. annual Nonoperating Income (Expense) for 2020 was -$922K, a 199% decline from 2019.
- LogicBio Therapeutics, Inc. annual Nonoperating Income (Expense) for 2019 was $935K, a 129% increase from 2018.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)